Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer
Bladder cancer (BLCA) is one of the most common malignant tumors of the urinary system, but the current therapeutic strategy based on chemotherapy and immune checkpoint inhibitor (ICI) therapy cannot meet the treatment needs, mainly owing to the endogenous or acquired apoptotic resistance of cancer...
Main Authors: | Zihan Zhao, Ning Jiang, Yulin Zhang, Yuhao Bai, Tianyao Liu, Tianhang Li, Hongqian Guo, Rong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.919829/full |
Similar Items
-
Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model
by: Shiwen Nie, et al.
Published: (2022-04-01) -
A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer
by: Zeyi Wang, et al.
Published: (2023-01-01) -
Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
by: Lixia Xu, et al.
Published: (2023-03-01) -
Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01) -
Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis
by: Xiaojie Liang, et al.
Published: (2022-08-01)